Literature DB >> 19258149

Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.

Michael O'Malley1, John Fowler, Asif M Ilyas.   

Abstract

PURPOSE: The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (ca-MRSA) appears to be increasing, but the timeliness of appropriate antibiotic delivery is often delayed. We retrospectively reviewed the prevalence of ca-MRSA infections in an urban setting, time from presentation to the hospital to appropriate antibiotic delivery, and differences in length of stay between the ca-MRSA and non-MRSA hand infections.
METHODS: We retrospectively reviewed all visits for hand infection cases to the emergency room of an urban academic medical center over a 12-month period. A formal hand infection algorithm was used in the treatment of each patient. All patients with culture-positive hand infections were included for evaluation. Infections determined to be nosocomial or not community-acquired were excluded. Patient demographics, laboratory studies, culture results, antibiotic delivery, and length of stay data were collected.
RESULTS: A total of 85 patients (55 male) with an average age of 39 years met the inclusion criteria. The overall prevalence rate of ca-MRSA hand infections was 55%. The average time to appropriate antibiotic delivery for ca-MRSA infection was 12 hours, versus 2.64 hours for non-MRSA hand infections (p > .5). The average length of stay was 4.0 days for ca-MRSA infections and 3.5 days for non-MRSA infections (p > .05). Univariate and multivariate analysis identified intravenous drug abuse and a serum white blood cell count of >8.7 as independent risk factors for ca-MRSA hand infections.
CONCLUSIONS: Community-acquired methicillin-resistant S. aureus infections of the hand continue to increase in urban settings. With the use of a formal hand infection treatment algorithm, we did not identify a statistical difference in appropriate antibiotic delivery time and length of stay between ca-MRSA and non-MRSA hand infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258149     DOI: 10.1016/j.jhsa.2008.11.021

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  11 in total

1.  The Effects of Early Antibiotic Administration on Bacterial Culture Growth From Hand Abscesses.

Authors:  Arianna Trionfo; Joseph J Thoder; Rick Tosti
Journal:  Hand (N Y)       Date:  2016-02-03

2.  Mixed Infections of the Paronychium with Prevotella bivia.

Authors:  Ather Mirza; Joseph J Bove; Joshua Litwa; Graham Appelbe
Journal:  J Hand Microsurg       Date:  2011-11-24

3.  Increasing Multidrug Antibiotic Resistance in MRSA Infections of the Hand: A 10-Year Analysis of Risk Factors.

Authors:  Justin M Kistler; Colin M Vroome; Frederick V Ramsey; Asif M Ilyas
Journal:  Hand (N Y)       Date:  2019-03-22

Review 4.  MRSA Incidence and Antibiotic Trends in Urban Hand Infections: A 10-Year Longitudinal Study.

Authors:  Justin M Kistler; Joseph J Thoder; Asif M Ilyas
Journal:  Hand (N Y)       Date:  2018-01-11

Review 5.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  Characterizing Hand Infections in an Underserved Population: The Role of Diabetic Status in Antibiotic Choice and Infection Location.

Authors:  Andrew J Hayden; Neil V Shah; Sarah G Stroud; Gregory S Penny; Steven A Burekhovich; Aadit T Shah; Erika Kuehn; Andrew Yang; Bassel G Diebo; Steven M Koehler
Journal:  J Hand Microsurg       Date:  2019-06-26

7.  Impact of methicillin-resistant Staphylococcus aureus on treatment of hand infections.

Authors:  Scott D Lifchez; David A Harriman
Journal:  Eplasty       Date:  2009-11-20

8.  Antibacterial, antioxidant, antifungal and anti-inflammatory activities of crude extract from Nitraria schoberi fruits.

Authors:  Javad Sharifi-Rad; Seyedeh Mahsan Hoseini-Alfatemi; Majid Sharifi-Rad; Jaime A Teixeira da Silva
Journal:  3 Biotech       Date:  2014-11-13       Impact factor: 2.406

Review 9.  Infections of the hand: an overview.

Authors:  Dimitrios A Flevas; Sophia Syngouna; Emmanouel Fandridis; Sotirios Tsiodras; Andreas F Mavrogenis
Journal:  EFORT Open Rev       Date:  2019-05-10

10.  Optimizing Treatment of Hand Infections: Is MRSA Coverage Always Necessary?

Authors:  Jeremie D Oliver; Brian C Pridgen; Heather E desJardins-Park; Catherine Curtin; Paige M Fox
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.